Revenue
2017
2018
2019
2020
2021
2022
2023
2024
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $57,674 | $618,197 | $5.5M | $2.4M | $90,543 | $671,295 | $733,153 | $773,468 | $443,797 |
| Gross profit | $2,563 | $232,040 | $11.0M | $8.3M | $3.5M | $101,064 | $130,433 | $263,264 | $154,393 |
| Research & development | — | $867,193 | $26.9M | $9.2M | $0 | — | — | — | — |
| Operating expenses | $279,100 | $10.7M | $107.7M | $32.4M | $3.2M | $780,578 | $239,750 | $374,090 | $131,110 |
| Operating income | −$276,537 | −$10.7M | −$96.7M | −$24.1M | −$259,985 | −$679,514 | −$109,317 | −$110,826 | $23,283 |
| EBITDAderived | — | −$7.3M | −$96.7M | −$24.1M | −$247,229 | — | — | — | — |
| Net income | $4.7M | −$77.3M | −$101.7M | −$25.0M | $467,725 | −$683,537 | $5,800 | −$127,642 | $19,166 |
| Basic EPSper diluted share | $0.00 | -$0.06 | -$0.27 | -$0.07 | $0.00 | -$0.03 | $0.00 | $0.00 | $0.00 |
| Diluted EPSper diluted share | $0.00 | -$0.06 | -$0.27 | -$0.07 | $0.00 | -$0.03 | $0.00 | $0.00 | $0.00 |